Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Impaired Hepatic Function”

55 trials

Showing 20 of 55 results

Very early researchUnknownNCT03673215
What this trial is testing

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

Who this might be right for
Liver Cirrhosis
Shenyang Sunshine Pharmaceutical Co., LTD. 58
Not applicableStudy completedNCT00305591
What this trial is testing

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Who this might be right for
CirrhosisHepatic Encephalopathy
Imperial College London 50
Early research (Phase 1)Study completedNCT01392807
What this trial is testing

Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function

Who this might be right for
Hepatic; Functional Disturbance
AstraZeneca 24
Not applicableStudy completedNCT05912933
What this trial is testing

Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Who this might be right for
Breast Cancer
Pfizer 733
Early research (Phase 1)Study completedNCT02005744
What this trial is testing

A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function

Who this might be right for
Liver Dysfunction
Chong Kun Dang Pharmaceutical 26
Early research (Phase 1)Ended earlyNCT04252417
What this trial is testing

HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects

Who this might be right for
Healthy VolunteersHepatic Impairment of Moderate Child Pugh Category
MedDay Pharmaceuticals SA 15
Early research (Phase 1)Study completedNCT01767688
What this trial is testing

A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 16
Early research (Phase 1)Study completedNCT01126086
What this trial is testing

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment
Sanofi 25
Early research (Phase 1)Study completedNCT01429337
What this trial is testing

PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 43
Early research (Phase 1)Study completedNCT04293029
What this trial is testing

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Jiangsu HengRui Medicine Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT00144248
What this trial is testing

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

Who this might be right for
HIV InfectionsHepatic Insufficiency
Boehringer Ingelheim 51
Early research (Phase 1)Study completedNCT00437424
What this trial is testing

Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 24
Testing effectiveness (Phase 2)UnknownNCT04454762
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function

Who this might be right for
Hepatocellular Carcinoma
Johannes Gutenberg University Mainz 20
Large-scale testing (Phase 3)Study completedNCT00604357
What this trial is testing

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

Who this might be right for
End Stage Liver DiseaseImpaired Renal Function
University of Regensburg 27
Early research (Phase 1)Study completedNCT01012284
What this trial is testing

TMC207 in Patients With Moderately Impaired Hepatic Function

Who this might be right for
Moderate Hepatic Impairment
Tibotec BVBA 16
Early research (Phase 1)Study completedNCT01863784
What this trial is testing

Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Janssen Research & Development, LLC 28
Not applicableStudy completedNCT04170309
What this trial is testing

Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases

Who this might be right for
Renal InsufficiencyHepatic InsufficiencyImmunosuppression
Advanz Pharma 428
Early research (Phase 1)Study completedNCT01111318
What this trial is testing

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

Who this might be right for
Hepatic InsufficiencyHealthy
Boehringer Ingelheim 36
Early research (Phase 1)Not Yet RecruitingNCT07394309
What this trial is testing

Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 30
Not applicableStudy completedNCT06245785
What this trial is testing

Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function

Who this might be right for
Hepatic Cancer
Tang-Du Hospital 2,200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation